From the CMS doc “Medicare Drug Value Negotiation Program: Chosen Medication for Preliminary Value
Applicability yr 2027“:

On January 17, 2025, CMS introduced the number of the next record of 15 Medicare Half D medication for the second negotiation cycle (preliminary worth relevant in yr 2027), primarily based on whole gross coated prescription drug prices below Medicare Half D and different standards as required by legislation.

Will the Medicare Drug Value Negotiation course of change now that Trump's inauguration takes place on Monday below the brand new administration? Anna Kaltenboeck notes in EndPoints Information:

… the subsequent authorities won’t have 'normal authority to alter core elements of the legislation', sure features of the method might be modified with out legislative motion.

For instance, CMS might change its tips or the best way it interprets elements of the legislation, corresponding to how typically it meets with drug makers, or what number of listening periods it holds. “The extent to which they play hardball with producers on this regard could change,” she stated.